Cannabis Bioscience International Holdings, Inc. (CBIH) Change in Accured Expenses (2023 - 2026)

Cannabis Bioscience International Holdings has reported Change in Accured Expenses for 4 years, with the latest figure at -$25993.0 in Q1 2026.

• Quarterly Change in Accured Expenses fell 274.71% year-over-year to -$25993.0 in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $127309.0 (up 266.35% YoY) and the FY2025 annual result came in at $22095.0, down 73.94% from the prior year.
• Change in Accured Expenses fell to -$25993.0 in Q1 2026 per CBIH's latest filing, from $115164.0 in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $115164.0 in Q4 2025 and troughed at -$61439.0 in Q2 2024.
• A 4-year average of $18803.8 and a median of $24420.0 in 2023 frame the typical range for Change in Accured Expenses.
• The sharpest annual moves came in 2024 and 2025: Change in Accured Expenses slumped 351.59% in 2024, then soared 286.24% in 2025.
• Over 4 years, Change in Accured Expenses stood at $43566.0 in 2023, then tumbled by 31.56% to $29817.0 in 2024, then jumped by 286.24% to $115164.0 in 2025, then plunged by 122.57% to -$25993.0 in 2026.
• According to Business Quant data, Change in Accured Expenses over the past three periods registered -$25993.0, $115164.0, and $952.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.